Teachers' Lived Experiences Regarding the Use of Therapy Dogs as a Behavior Management Strategy

2021 ◽  
Author(s):  
Rhonda M. Kelsey
2016 ◽  
Vol 53 (3) ◽  
pp. 171-176
Author(s):  
Patricia H. Sheehey ◽  
Jenny C. Wells

Response interruption and redirection, commonly referred to as RIR, is an evidence-based intervention that has been demonstrated to quickly reduce moderate to high levels of vocal stereotypy in children with autism spectrum disorder. The RIR intervention is a simple, three-step procedure that can be embedded in classroom instruction with minimal planning. This column describes the procedure and provides a troubleshooting guide to aid practitioners in effectively implementing the RIR behavior management strategy.


1983 ◽  
Vol 8 (4) ◽  
pp. 258-264 ◽  
Author(s):  
Linda Higbee Mandlebaum ◽  
Steven C. Russell ◽  
James Krause ◽  
Martha Gonter

Although Assertive Discipline is widely advocated as a classroom management system, there currently exists specious evidence to support this approach. The basic philosophy, necessary competencies, and procedures associated with Assertive Discipline are reviewed. The effects of an Assertive Discipline program on reducing out-of-seat and inappropriate talking among students of a third grade class were investigated using a reversal design. Results indicate a functional relationship between the program and the dependent measures. Social validation of the program is provided by informal measures of teacher behavior and by interviews with the principal, teacher, and students. It is concluded that the Assertive Discipline program is an effective and practical behavior management strategy that can yield socially valid outcomes.


2019 ◽  
Author(s):  
Young Ho Yun ◽  
EunKyo Kang ◽  
Young Min Cho ◽  
Sang Min Park ◽  
Yong-Jin Kim ◽  
...  

BACKGROUND In addition to medication, health behavior management is crucial in patients with multiple risks of cardiovascular mortality. OBJECTIVE This study aimed to examine the efficacy of a 3-month Smart Management Strategy for Health–based electronic program (Smart Healthing). METHODS A 2-arm randomized controlled trial was conducted to assess the efficacy of Smart Healthing in 106 patients with at least one indicator of poor disease control and who had hypertension, diabetes, or hypercholesterolemia. The intervention group (n=53) took part in the electronic program, which was available in the form of a mobile app and a Web-based PC application. The program covered 4 areas: self-assessment, self-planning, self-learning, and self-monitoring by automatic feedback. The control group (n=53) received basic educational material concerning disease control. The primary outcome was the percentage of participants who achieved their clinical indicator goal after 12 weeks into the program: glycated hemoglobin (HbA<sub>1c</sub>) &lt;7.0%, systolic blood pressure (SBP) &lt;140 mmHg, or low-density lipoprotein cholesterol &lt;130 mg/dL. RESULTS The intervention group showed a significantly higher success rate (in comparison with the control group) for achieving each of 3 clinical indicators at the targeted goal levels (<italic>P</italic>&lt;.05). Only the patients with hypertension showed a significant improvement in SBP from the baseline as compared with the control group (72.7% vs 35.7%; <italic>P</italic>&lt;.05). There was a significant reduction in HbA<sub>1c</sub> in the intervention group compared with the control group (difference=0.54%; <italic>P</italic>≤.05). In the intervention group, 20% of patients with diabetes exhibited a ≥1% decrease in HbA<sub>1c</sub> (vs 0% among controls; <italic>P</italic>≤.05). CONCLUSIONS A short-term self-management strategy-based electronic program intervention may improve clinical outcomes among patients with cardiovascular risks. CLINICALTRIAL ClinicalTrials.gov NCT03294044; https://clinicaltrials.gov/ct2/show/NCT03294044


1989 ◽  
Vol 24 (3) ◽  
pp. 295-303 ◽  
Author(s):  
Charles M. Heuchert

A behavior management strategy based on the concepts of reality therapy and control theory is outlined and discussed.


10.2196/15057 ◽  
2020 ◽  
Vol 22 (1) ◽  
pp. e15057
Author(s):  
Young Ho Yun ◽  
EunKyo Kang ◽  
Young Min Cho ◽  
Sang Min Park ◽  
Yong-Jin Kim ◽  
...  

Background In addition to medication, health behavior management is crucial in patients with multiple risks of cardiovascular mortality. Objective This study aimed to examine the efficacy of a 3-month Smart Management Strategy for Health–based electronic program (Smart Healthing). Methods A 2-arm randomized controlled trial was conducted to assess the efficacy of Smart Healthing in 106 patients with at least one indicator of poor disease control and who had hypertension, diabetes, or hypercholesterolemia. The intervention group (n=53) took part in the electronic program, which was available in the form of a mobile app and a Web-based PC application. The program covered 4 areas: self-assessment, self-planning, self-learning, and self-monitoring by automatic feedback. The control group (n=53) received basic educational material concerning disease control. The primary outcome was the percentage of participants who achieved their clinical indicator goal after 12 weeks into the program: glycated hemoglobin (HbA1c) <7.0%, systolic blood pressure (SBP) <140 mmHg, or low-density lipoprotein cholesterol <130 mg/dL. Results The intervention group showed a significantly higher success rate (in comparison with the control group) for achieving each of 3 clinical indicators at the targeted goal levels (P<.05). Only the patients with hypertension showed a significant improvement in SBP from the baseline as compared with the control group (72.7% vs 35.7%; P<.05). There was a significant reduction in HbA1c in the intervention group compared with the control group (difference=0.54%; P≤.05). In the intervention group, 20% of patients with diabetes exhibited a ≥1% decrease in HbA1c (vs 0% among controls; P≤.05). Conclusions A short-term self-management strategy-based electronic program intervention may improve clinical outcomes among patients with cardiovascular risks. Trial Registration ClinicalTrials.gov NCT03294044; https://clinicaltrials.gov/ct2/show/NCT03294044


Sign in / Sign up

Export Citation Format

Share Document